|Day Low/High||0.00 / 0.00|
|52 Wk Low/High||19.67 / 28.51|
Companies from Amazon to Wipro have a stake in the policies governing tech workers and immigration.
Results from Evaluation of Real-World Patients Presented at American Thoracic Society International Conference
Acquisition Expands Company's Structural Heart Portfolio; Increases Offerings for the Treatment of Patients with Valvular Heart Disease
Largest Prospective Study of the WATCHMAN Device Presented as Late-Breaking Trial at Heart Rhythm 2017
Late-Breaker Data Presented at Heart Rhythm 2017
Pivotal Data From REPRISE III and EWOLUTION Among Four Late-breaking Clinical Trials to be Presented
From Abbott Labs to Wynn, these names rate checking out.
New Devices Combine Longest-Lasting Battery Technology, Therapy Optimization and HeartLogic™ Heart Failure Diagnostics
It's a wonder to me how split this market really is.
Late-Breaking Clinical Trials Feature Subcutaneous Implantable Defibrillator and WATCHMAN™ Left Atrial Appendage Closure Device
Stocks hold onto slight to modest gains Thursday afternoon after positive earnings help to offset a slump in crude oil prices and a decline in energy names.
Stocks turn mixed on Thursday after a slump in crude oil prices, and a decline in energy names, snarl earlier upward momentum.
Stock futures creep higher on Thursday as Wall Street returns its attention to positive earnings for market direction after a day focused on the White House's tax reform plans.
Here are Tuesday's top research calls, including downgrades for Amazon and C.R. Bard, and new coverage of CyrusOne and Dow Chemical.
A bullish market and another quant upgrade could push BSX past our $31 target.
TheStreet Quant Ratings provides fair and objective information to help you make educated investing decisions. We rate over 4,200 stocks daily and provide 5-page PDF reports for each stock. These ratings can change daily and today's changes are reflected in the email below. If you are looking to check-up on the stocks you currently own or are looking for new ideas, you can find our full database of password-protected ratings reports in our proprietary ratings screener: http://www.thestreet.com/k/qr/flat/stock-screener.html Upgrades: BSX, RMP, TGEN Downgrades: ESCA, VYGR Initiations: None Read on to get TheStreet Quant Ratings' detailed report:
Full-steam ahead for earnings season in the coming week as a range of industry leaders across a swath of sectors release their recent quarterly performances.
MADIT S-ICD Trial to Study EMBLEM™ MRI Subcutaneous Implantable Defibrillator (S-ICD) System; Trial Recruitment Part of Pilot Initiative to Increase Percentage of Females Enrolled in Clinical Studies
Canaccord is bullish on Edwards Lifescience stock.
From Aetna to United Technologies, these names are hot.
Their overseas business has been carrying them.
Symetis is a structural heart company focused on minimally-invasive transcatheter aortic valve implantation (TAVI) devices.